Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer. - PubMed - NCBI

Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer. - PubMed - NCBI

Acta Oncol. 2019 Aug 5:1-6. doi: 10.1080/0284186X.2019.1648860. [Epub ahead of print]

Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.

Terkelsen T1, Rønning H2, Skytte AB1,3.

Author information

1

a Department of Clinical Genetics, Aarhus University Hospital, Aarhus , Denmark.

2

b Plastic and Breast Surgery, Aarhus University Hospital, Aarhus , Denmark.

3

c Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus , Denmark.

Abstract

Background: Preoperative genetic testing affects the surgical decision-making among women with breast cancer. To avoid breast-conserving surgery and to offer the possibility of mastectomy with immediate reconstruction in high-risk patients, genetic testing for pathogenic variants in BRCA1 or BRCA2 and a pedigree-based familial breast cancer risk assessment was offered to younger women with breast cancer in Denmark. We evaluated the impact of the risk stratification through genetic counseling on the uptake of contralateral prophylactic mastectomy (CPM). Material and methods: The prospective cohort study included all women with unilateral breast cancer before the age of 45 who participated in a genetic counseling program during their primary diagnostics in the Central Denmark Region (2013-2018). Each patient was followed from the time of the genetic test result to the end of follow-up to estimate the long-term uptake of CPM as a competing risk-adjusted cumulative incidence. We compared the uptake of CPM between the various genetic risk categories, ages of onset, and family histories in a multivariable Cox proportional hazards regression model, reporting hazard ratios (HR) with two-sided 95% confidence intervals (CIs). Results: 156 females, aged 21-44, learned their genetic test result within a median of 92 days [interquartile range (IQR): 75-114]. The maximal follow-up was 3.8 years (median 1.8; IQR: 0.49-2.5), after which 33% (95% CI: 24-42%) of the patients had undergone CPM. The uptake of CPM was inversely associated with the age of onset (HR 0.92; 95% CI: 0.86-0.98) and significantly higher among BRCA carriers (HR 2.9; 95% CI: 1.3-6.8) and patients from the high risk of breast cancer families (HR 5.6; 95% CI: 1.9-16) compared to the lower genetic risk categories. Conclusion: The risk stratification obtained through genetic counseling had a considerable impact on the surgical decision-making among younger women with breast cancer at long-term follow-up.

PMID:

 

31379231

 

DOI:

 

10.1080/0284186X.2019.1648860